Moffitt Cancer Center Logo
 

Claudia G. Berman, MD

Where You Are:

Claudia G. Berman, MD

Radiology

 
 

BOARD CERTIFICATION:
          •  Diagnostic Radiology

FELLOWSHIP:
          •  University of Pennsylvania - Nuclear Medicine
          •  University of South Florida - Magnetic Resonance Imaging

RESIDENCY:
          •  Mercy Catholic Medical Center, Philadelphia - Diagnostic Imaging

MEDICAL SCHOOL:
          •  Jefferson Medical College, PA - MD

  • Kumar V, Nath K, Berman CG, Kim J, Tanvetyanon T, Chiappori AA, Gatenby RA, Gillies RJ, Eikman EA. Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med. 2013 Mar;38(3):175-182. Pubmedid: 23354032. Pmcid: PMC3578161.

  • Finkelstein SE, Iclozan C, Bui MM, Cotter MJ, Ramakrishnan R, Ahmed J, Noyes DR, Cheong D, Gonzalez RJ, Heysek RV, Berman C, Lenox BC, Janssen W, Zager JS, Sondak VK, Letson GD, Antonia SJ, Gabrilovich DI. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int J Radiat Oncol Biol Phys. 2012 Feb;82(2):924-932. Pubmedid: 21398051.

  • Zager JS, Brodsky S, Berman CG. Imaging of Merkel cell carcinoma. Curr Probl Cancer. 2010 Jan;34(1):65-76. Pubmedid: 20371075.

  • Khera S, Kiluk J, Hasson D, Meade T, Meyers M, Dupont E, Berman C, Cox C. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008 May;14(3):250-254. Pubmedid: 18476883.

  • Berman CG. Recent advances in breast-specific imaging. Cancer Control. 2007 Oct;14(4):338-349. Pubmedid: 17914334.

  • Li L, Wu Z, Salem A, Chen Z, Chen L, George F, Kallergi M, Berman C. Computerized analysis of tissue density effect on missed cancer detection in digital mammography. Comput Med Imaging Graph. 2006 Jul;30(5):291-7. Pubmedid: 16837164.

  • Kallergi M, Lucier B, Berman C, Hersh M, Kim J, Szabunio M, Clark R. High-performance wavelet compression for mammography: localization response operating characteristic evaluation. Radiology. 2006 Jan;238(1):62-73. Pubmedid: 16373759.

  • Kallergi M, Heine J, Berman C, Hersh M, Romilly A, Clark R. Improved interpretation of digitized mammography with wavelet processing: a localization response operating characteristic study. Ajr Am J Roentgenol. 2004;182(3):697-703. Pubmedid: 14975972.

  • Kallergi M, Berman C, Cressman J, Loeffler W, Pat Romilly A, Szabunio M, Vedam P, Venugopal P, Walker J. Clinical evaluation of a new digitizing device for improved film mammography. Acad Radiol. 2004;11(11):1242-1250. Pubmedid: 15561571.

  • Cox C, Furman B, Stowell N, Ebert M, Clark J, Dupont E, Shons A, Berman C, Beauchamp J, Gardner M, Hersch M, Venugopal P, Szabunio M, Cressman J, Diaz N, Vrcel V, Fairclough R. Radioactive seed localization breast biopsy and lumpectomy: can specimen radiographs be eliminated?. Ann Surg Oncol. 2003 Nov;10(9):1039-1047. Pubmedid: 14597442.

  • Kamath V, Giuliano R, Dauway E, Cantor A, Berman C, Ku N, Cox C, Reintgen D. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001;136(6):688-692. Pubmedid: 11387010.

  • Goscin C, Berman C, Clark R. Magnetic resonance imaging of the breast. Cancer Control. 2001;8:399-406. Pubmedid: 11579335.

  • Bass SS, Cox CE, Salud CJ, Lyman G, McCann C, Dupont E, Berman C, Reintgen D. The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg. 2001;192(1):9-16. Pubmedid: 11192930.

  • Dupont E, Kamath V, Ramnath E, Shivers S, Cox C, Berman C, Leight G, Ross J, Blumencranz P, Reintgen DS. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol. 2001;8(4):354-359. Pubmedid: 11352310.

  • Chirikos T, Berman C, Luther S, Clark R. Cost consequences of sentinel lymph node biopsy in the treatment of breast cancer: a preliminary analysis. Int J Technol Assess Health Care. 2001;17(4):626-631. Pubmedid: 11758307.

  • Gray R, Salud C, Nguyen K, Dauway E, Friedland J, Berman C, Peltz E, Whitehead G, Cox C. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8(9):711-715. Pubmedid: 11597011.

  • Berman C, Choi J, Hersh M, Clark R. Melanoma lymphoscintigraphy and lymphatic mapping. Semin Nucl Med. 2000;30(1):49-55. Pubmedid: 10656243.

  • Berman C, Clark R. Positron emission tomography in initial staging and diagnosis of persistent or recurrent disease: a review. Curr Opin Oncol. 2000;12(2):132-137. Pubmedid: 10750724.

  • Cox C, Bass S, McCann C, Ku N, Berman C, Durand K, Bolano M, Wang J, Peltz E, Cox S, Salud C, Reintgen D, Lyman G. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med. 2000;51:525-542. Pubmedid: 10774480.

  • Smith D, Messina J, Perrott R, Berman C, Reintgen D, Cruse C, Glass F, DeConti R, Trotti A, Fenske N. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000;7(1):72-83. Pubmedid: 10740663.

  • Bass S, Dauway E, Mahatme A, Ku N, Berman C, Reintgen D, Cox C. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancer <1 centimeter (T1a-T1b)Am Surg. 1999 Sep;65(9):857-61; discussion 861-2. Am Surg. 1999;65(9):857-861. Pubmedid: 10484089.

  • Berman CG, Goscin C, Kim JJ, Miller MS. Lymphoscintigraphy in malignant melanoma and breast cancer. Surg Oncol Clin N Am. 1999 Jul;8(3):401-12, vii. Pubmedid: 10448685.

  • Brobeil A, Cruse CW, Messina JL, Glass LF, Haddad FF, Berman CG, Marshburn J, Reintgen DS. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am. 1999 Jul;8(3):435-45, viii. Pubmedid: 10448688.

  • Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, Cruse CW, Berman CG, Reintgen DS. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol. 1999 Mar;6(2):144-149. Pubmedid: 10082038.

  • Messina J, Glass L, Cruse C, Berman C, Ku N, Reintgen D. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg. 1999;23(6):686-690. Pubmedid: 10366151.

  • Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol. 1999;6(6):553-561. Pubmedid: 10493623.

  • Kamath D, Milotes G, Lyman G, Rapaport D, Cruse C, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage patterns in patients with grossly involved nodal basins. Ann Surg Oncol. 1999;6(4):345-349. Pubmedid: 10379854.

  • Bass S, Dauway E, Mahatme A, Ku N, Berman C, Reintgen D, Cox C. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers < 1centimeter (T1A-T1B). Am Surg. 1999;65(9):857-862.

  • Dauway E, Giuliano R, Haddad F, Pendas S, Costello D, Cox C, Berman C, Ku N. Lymphatic mapping in breast cancer. Hematol Oncol Clin N Amer. 1999;13(2):349-371. Pubmedid: 10363135.

  • Pendas S, Dauway E, Cox C, Giuliano R, Ku N, Schreiber R, Berman C, Reintgen D. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999;65(6):500-506. Pubmedid: 10366202.

  • Cox C, Pendas S, Cox J, Joseph E, Shons A, Yeatman T, Ku N, Lyman G, Berman C, Haddad F, Reintgen D. Guidelines for sentinel node biopsy and lymphatic mapping of breast cancer patients. Ann Surg. 1998;227(5):645-645. Pubmedid: 9605656.

  • Brobeil A, Berman C, Cruse C, DeConti R, Cantor A, Lyman G, Rapaport D, Joseph E, Wells K, Reintgen D. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol. 1998;5(4):376-383. Pubmedid: 9641461.

  • Venugopal P, Berman C, Robinson L. The pleural tent: radiographic appearance. Cancer Control. 1998;5(1):41-41. Pubmedid: 10761016.

  • Reintgen D, Haddad F, Pendas S, Berman C, Ku N, Glass F, Messina J, Cox C. Sentinel node biopsy in ductal carcinoma in situ patients. Scientific America Surgery. 1998;12(9):1283-1292. Pubmedid: noPMID.

  • Cox C, Huddad F, Bass S, Cox J, Ku N, Berman C, Shons A, Pendas S, Reintgen D, Yeatman T. Lymphatic mapping in the treatment of breast cancer. Oncology. 1998;12(9):1283-1298. Pubmedid: 9778675.

  • Shivers S, Wang X, Li W, Joseph E, Messina J, Glass L, DeConti R, Cruse W, Berman C, Fenske N, Lyman G, Reintgen D. Molecular staging of malignant melanoma - correlation with clinical outcome. Jama. 1998;280(16):1410-1415. Pubmedid: 9801000.

  • Joseph E, Glass F, Glass J, Messina J, DeConti R, Cruse C, Rapaport D, Berman C, Fenske N, Reintgen D. The results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998;5:119-125. Pubmedid: 9527264.

  • Kallergi M, Gavrielides M, He L, Berman C, Kim J, Clark R. Simulation model of mammographic calcifications based on the American College of Radiology Breast Imaging Reporting and Data System, or BIRADS. Acad Radiol. 1998;5(10):670-679. Pubmedid: 9787837.

  • Reintgen D, Cox C, Haddad F, Costello D, Berman C. The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer. J Nucl Med. 1998;39(12):22N-36N. Pubmedid: 9867132.

  • Brobeil A, Kamath D, Cruse CW, Rapaport DP, Wells KE, Shons AR, Messina JL, Glass LF, Berman CG, Puleo CA, Reintgen DS. The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc. 1997 Mar;84(3):157-160. Pubmedid: 9143166.

  • Reintgen D, Joseph E, Lyman G, Yeatman T, Balducci L, Ku N, Berman C, Shons A, Wells K, Horton J, Greenberg H, Nicosia S, Clark R, Shivers S, Li W, Wang X, Cantor A, Cox C. The role of selective lymphadenectomy in breast cancer. Cancer Control. 1997;4(3):211-219. Pubmedid: 10763020.

  • Kamath D, Rapaport D, DeConti R, Cruse C, Wells K, Glass L, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997;84(3):182-187. Pubmedid: 9143170.

  • Joseph E, Messina J, Glass FL, Cruse CW, Rapaport DP, Berman C, Greenberg H, Reintgen DS. Radioguided surgery for the ultrastaging of melanoma. Cancer J Sci Am. 1997;3(6):341-345. Pubmedid: 9403046.

  • Wells K, Rapaport D, Cruse C, Payne W, Albertini J, Berman C, Lyman G, Reintgen D. Sentinel node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997;100:591-594. Pubmedid: 9283554.

  • Schreiber R, Pendas S, Ku N, Reintgen D, Shons A, Berman C, Boulware D, Cox C. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol. 1997;6(1):95-101. Pubmedid: 10030421.

  • Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen D. Multiple primary melanomas: implications for screening and follow-up programs. Ann Surg Oncol. 1997;4:19-23. Pubmedid: 8985513.

  • Ramnath E, Kamath D, Brobeil A, Stall A, Kamath V, Cruse C, Glass F, Messina J, Fenske N, Berman C, Cantor A, Cuthbertson D, Reintgen D, Ross M. Lymphatic mapping for melanoma: long-term results of regional nodal sampling with radioguided surgery. Cancer Control. 1997;4:483-490. Pubmedid: 10763056.

  • Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse C, Rapaport D, Berman C, Glass L, Fenske N, Einstein, Jr. A, Lyman G. Investment in new technology research can save future health care dollars. J Fla Med Assoc. 1997;84(3):175-181. Pubmedid: 9143169.

  • Messina J, Reintgen D, Cruse C, Rapaport D, Berman C, Fenske N, Glass L. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997;4(5):389-395. Pubmedid: 9259965.

  • Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996 Aug;22(8):715-720. Pubmedid: 8780765.

  • Glass L, Fenske N, Messina J, Cruse C, Rapaport D, Berman C, Puleo C, Heller R, Miliotes G, Albertini J, Reintgen D. The role of selective lymphadenectomy in the management of patients with malignant melanomoa. Dermatol Surg. 1996;21:979-983.

  • Brobeil A, Berman C, Clark R, Cox C, Reintgen D. Medical-legal pitfalls for the breast surgeon: incomplete mammographic localization of suspicious lesions and the correlation between palpable and mammographic abnormalities. Am Surg. 1996;6:484-487. Pubmedid: 8651534.

  • Albertini J, Lyman G, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen D. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Jama. 1996;276(22):1818-1822. Pubmedid: 8946902.

  • Kallergi M, Clarke L, Qian W, Gavrielides M, Venugopal P, Berman C, Holman-Ferris S, Miller M, Clark R. Interpretation of calcifications in screen/film, digitized, and wavelet-enhanced monitor displayed mammograms: an ROC study. Acad Radiol. 1996;3:285-293. Pubmedid: 8796676.

  • Meliotis G, Albertini J, Berman C, Heller R, Messina J, Glass L, Cruse C, Rapaport D, Puleo C, Fenske N, Petsofglov C, DeConti R, Lyman G. The tumor biology of melanoma nodal metastasis. Am Surg. 1996;62:81-88. Pubmedid: 8540654.

  • Berman C, Choi J. Radioimmunodetection of colorectal carcinoma. Cancer Control. 1996;3(1):48-50. Pubmedid: 10825276.

  • Albertini J, Cruse C, Rapaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass L, Fenske N, Reintgen D. Intraoperative radiolymphoscinitigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223(2):217-224. Pubmedid: 8597518.

  • Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg. 1995 Nov;21(11):979-983. Pubmedid: 7582838.

  • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et a. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb;61(2):97-101. Pubmedid: 7856986 .

  • Reintgen D, Albertini J, Berman C, Cruse C, Fenske N, Glass L, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate nodal staging of malignant melanoma. Cancer Control. 1995;2(5):405-414. Pubmedid: 10862181.

  • Berman C. The role of lymphoscintigraphy in staging. Cancer Control. 1995;2(5):439-451. Pubmedid: 10862185.

  • Phuphanich S, Berman C, Greenberg H, Murtagh F, Prockop L. Thallium-201 SPECT index of radiation necrosis and malignant brain tumor with pathological correlation and survival. J Neuroimaging. 1995;5:68-68. Pubmedid: noPMID.

  • Reintgen D, Albertini J, Miliotes G, Berman C, Cruse C, Fenske N, Glasser S, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Cont. 1995;4:183-197. Pubmedid: noPMID.

  • Wells K, Cruse C, Daniels S, Berman C, Norman Jr. J, Reintgen D. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994;93:757-761.

  • Reintgen D, Cruse C, Wells K, Berman C, Fenske N, Glass L, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rapaport D, Seigler H, Balch C. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220(6):759-767.

  • Wang X, Heller R, Cruse C, VanVoorhis N, Glass L, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metasases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994;220:768-774.

  • Reintgen D, Cruse C, Berman C, Norman Jr. J. A redefinition of skin mapping with the use of lymphoscintigraphy: implications for elective lymph node dissection for melanoma. Melanoma Res. 1993;3:34-34.

  • Berman C, Reintgen D. Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol. 1993;9:232-238.

  • Reintgen D, Cox C, Greenberg H, Baekey P, Nicosia S, Berman C, Clark R, Lyman G. The medical legal implications of following mammographic breast masses. Am Surg. 1993;59(2):99-105.

  • Norman Jr. J, Wells K, Kearney R, Cruse C, Berman C, Reintgen D. Identification of lymphatic basins in patients with cutaneous melanoma. Semin Surg Oncol. 1993;9:224-227.

  • Cox C, Greenberg H, Fleisher D, Clark R, Nicosia S, Berman C, Ku N, Fiorica J, Reintgen D. Natural history and clinical evaluation of the lumpectomy scar. Am Surg. 1993;59:55-59.

  • Brown K, Hazelton T, Parsons A, Fiorica J, Berman C, Silbiger M. PC-based fullcolor composite display in MR imaging of adnexal masses: preliminary clinical application with quantitative image analysis and pathologic correlation. J Comput Assist Tomogr. 1993;17:995-1005.

  • Reintgen D, Berman C, Cox C, Baekey P, Nicosia S, Greenberg H, Bush C, Lyman G, Clark R. The anatomy of missed breast cancers. Surg Oncol. 1993;2:65-75.

  • Brown H, Hazelton T, Parsons A, Fiorica J, Berman C, Silbiger M. PC-based multiparameter full-color display for tissue segmentation in MRI of adnexal masses. J Comput Assist Tomogr. 1993;17(6):993-1005.

  • Reintgen D, Cruse C, Schroer K, Glass L, Saba H, Puleo C, King J, Berman C, Hannon L, Cox C. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. Semin Surg Oncol. 1993;9:208-214.

  • Reintgen D, Cruse C, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass L, Alvarez L, Brozena S, Fenske N, Fabri P. The effectiveness of skin cancer screening and continuing education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992;1:379-384.

  • Heal A, Tyson I, Greenberg H, Roberts W, Nicosia S, Berman C, Silbiger M. Pharmacokinetics, dosimetry and clinical evaluation of 131-I-HMFG1 MoAb in the therapy of colorectal and ovarian carcinoma. Antibody Immunoconjugates Radiopharm. 1992;5:1-12.

  • Berman C, Norman Jr. J, Cruse C, Reintgen D, Clark R. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992;28(1):29-32.

  • Barton D, Berman C, Cavanagh D, Roberts W, Hoffman M, Fiorica J, Finan M. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol. 1992;46:341-344.

  • Heal A, Tyson I, Greenberg H, Balducci L, Ketch R, Tenorio L, Berman C, Silbiger M. Evaluation of multiple infusions (IP) of 131-I-HMFG1 MoAb in ovarian and colorectal carcinoma patients and a nude mouse xenograft with and without IV use of unlabeled MoAb. Antibody Immunoconjugates Radiopharm. 1992;5:86-86.

  • Berman C, Clark R. Diagnostic imaging and cancer. Prim Care. 1992;19:677-713.

  • Kallergi M, Berman C, Heine J, Hersh M, Hooper L, Kim J, Miller M, Galbo C, Thomas J, Clark R. Effect of default display and presentation protocol on softcopy mammography. In: Digital Mammography IWDM 2002. New York, NY: Springer-Verlag; 2003;202.

  • Dauway E, Giuliano R, Haddad F, Pendas S, Costello D, Cox C, Berman C, Ku N, Reintgen D. Lymphatic mapping in breast cancer. In: James M, ed. Hematology/Oncology Clinics of North America:brachytherapy. 13 ed. Philadelphia, PA: W.B. Saunders Company; 1999.

  • Harris E, Lafond G, Arrington J, Berman C, Brodsky N. The head and neck. In: Oncologic Imaging: a clinical perspective. The McGraw Hill Companies; 1998;79-118.

  • Berman C, Brodsky N, Clark R. Oncologic Imaging. 2 ed. W.B. Saunders Company; 2002.

Nuclear medicine & PET